Skip to main
CCRN

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 5 analyst ratings
Hold
Strong Buy 20%
Buy 0%
Hold 80%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare is set to go private in a $437 million deal with Knox Lane, which presents a potential upside for the company as it becomes a privately held platform company in Knox Lane's portfolio. While the Q1/26 results showed a decline in revenue due to factors such as a normalization in demand and cost-cutting measures in the healthcare industry, the company still exceeded earnings expectations. Additionally, potential upside risks include investments in new technology and a potential surge in demand for temp healthcare workers due to a new pandemic outbreak.

Bears say

Cross Country Healthcare is facing a challenging market environment with an 18% drop in total revenues and a 130 basis point contraction in margins. While their AI-powered digital platform and recent acquisition by Knox Lane may provide some relief, there is still skepticism about their ability to recover and compete in the travel nursing market. Despite an attractive purchase price by Knox Lane, there is uncertainty around the timing and execution risks of the acquisition.

CCRN has been analyzed by 5 analysts, with a consensus rating of Hold. 20% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 5 analysts, CCRN has a Hold consensus rating as of Jul 15, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.55, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.55, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.